Ligand validation:4FBY

SQD: 1,2-DI-O-ACYL-3-O-[6-DEOXY-6-SULFO-ALPHA-D-GLUCOPYRANOSYL]-SN-GLYCEROL

SQD is a Ligand Of Interest in 4FBY designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4FBY_SQD_A_409	6%	33%	0.355	0.796	1.21	1.44	4	9	0	0	94%	0.9444
4FBY_SQD_G_401	6%	42%	0.374	0.8	1.18	1.06	4	4	0	0	100%	1
4FBY_SQD_G_410	4%	32%	0.386	0.77	1.21	1.46	4	9	0	0	94%	0.9444
4FBY_SQD_B_627	2%	31%	0.414	0.68	1.28	1.47	5	9	0	0	87%	0.8704
4FBY_SQD_N_601	2%	29%	0.44	0.701	1.28	1.54	5	10	0	0	87%	0.8704
4FBY_SQD_S_102	1%	36%	0.579	0.816	1.31	1.22	5	7	0	0	83%	0.8333
4FBY_SQD_B_624	1%	30%	0.449	0.677	1.34	1.45	5	7	0	0	80%	0.7963
4FBY_SQD_F_101	1%	36%	0.608	0.767	1.3	1.22	4	8	0	0	83%	0.8333
4FBY_SQD_A_414	0%	42%	0.571	0.627	1.17	1.08	4	4	0	0	100%	1
4FBY_SQD_Q_408	0%	30%	0.595	0.638	1.35	1.45	5	6	0	0	80%	0.7963
5V2C_SQD_a_413	94%	21%	0.075	0.976	1.12	2.14	4	12	0	0	100%	1
6DHE_SQD_A_412	78%	20%	0.113	0.961	1.05	2.27	5	14	0	0	96%	0.963
8IRC_SQD_a_411	77%	29%	0.119	0.96	0.96	1.83	3	13	0	0	100%	1
8IR5_SQD_a_411	76%	31%	0.123	0.958	0.95	1.77	3	13	0	0	100%	1
8IRF_SQD_a_410	76%	29%	0.125	0.96	0.96	1.83	3	13	0	0	100%	0.49
8IR8_SQD_a_409	75%	31%	0.126	0.96	0.95	1.77	3	13	0	0	100%	0.4

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.